Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

…, PA Tambyah, S Tiberi, A Torre, D Visca… - European …, 2020 - Eur Respiratory Soc
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis

…, DM Hansell, NSL Goh, CJ Zappala, D Visca… - The Journal of …, 2013 - jrheum.org
Objective. Biomarkers of progression of interstitial lung disease (ILD) are needed to allow
early therapeutic intervention in patients with scleroderma-associated disease (SSc-ILD). …

Pulmonary rehabilitation in patients recovering from COVID-19

…, M Paneroni, S Belli, M Aliani, A Gandolfo, D Visca… - Respiration, 2021 - karger.com
Background: In hospitalized patients recovering from the SARS-coronavirus-2 disease 19 (COVID-19),
high prevalence of muscle weakness and physical performance impairment has …

Electrocardiographic features of patients with COVID-19 pneumonia

F Angeli, A Spanevello, R De Ponti, D Visca… - European journal of …, 2020 - Elsevier
Background . The electrocardiographic (ECG) changes which may occur during hospitalization
for COVID-19 have not yet been comprehensively assessed. Patients and methods . We …

[HTML][HTML] MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

…, A García-Basteiro, R Centis, D Visca… - International Journal of …, 2020 - Elsevier
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …

[HTML][HTML] Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and …

…, MJ van Der Werf, D Visca… - European …, 2020 - Eur Respiratory Soc
Major epidemics, including some that qualify as pandemics, such as severe acute
respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/…

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

…, D Zhurkin, M Zignol, D Visca… - European …, 2019 - Eur Respiratory Soc
The World Health Organization (WHO) recommends that countries implement pharmacovigilance
and collect information on active drug safety monitoring (aDSM) and management of …

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised …

D Visca, L Mori, V Tsipouri, S Fleming… - The Lancet …, 2018 - thelancet.com
Background In fibrotic interstitial lung diseases, exertional breathlessness is strongly linked
to health-related quality of life (HRQOL). Breathlessness is often associated with oxygen …

SARS-CoV-2 vaccines: Lights and shadows

F Angeli, A Spanevello, G Reboldi, D Visca… - European journal of …, 2021 - Elsevier
Vaccines to prevent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicit
an immune neutralizing response. Some concerns have been raised regarding the safety of …

Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group …

…, F Cherubino, A Spanevello, D Visca… - The Lancet …, 2020 - thelancet.com
Background Whether blood eosinophil counts and exhaled nitric oxide (FeNO) are associated
with important outcomes in mild asthma is unclear. In this prespecified subgroup analysis …